Improving the effectiveness of cancer therapy using inhibitors of p38 MAPK and MK-2 signaling pathways

Alimbetov, D. (Speaker)

Activity: Talk or presentation typesOral presentation


Abstract was chosen for Oral Presenation
PeriodNov 13 2017
Held atAging and Cancer
Event typeConference
LocationShanghai, China
Degree of RecognitionInternational


  • p38/Mk2 pathway, cancer therapy, small molecules, chemotherapy